Operating Lease, Liability in USD of Lantern Pharma Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease.
Summary
Lantern Pharma Inc. quarterly Operating Lease, Liability history and change rate from Q2 2021 to Q3 2025.
  • Lantern Pharma Inc. Operating Lease, Liability for the quarter ending September 30, 2025 was $94K, a 67.7% decline year-over-year.
Operating Lease, Liability, Quarterly (USD)
Operating Lease, Liability, YoY Quarterly Change (%)

Lantern Pharma Inc. Quarterly Operating Lease, Liability (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $94K -$197K -67.7% Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $145K -$73.7K -33.7% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $195K +$1.35K +0.7% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 $244K +$9.19K +3.92% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $291K +$16.7K +6.09% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $219K -$95.2K -30.3% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $194K -$66.6K -25.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $234K +$182K +343% Dec 31, 2023 10-K 2025-03-27
Q3 2023 $275K +$183K +198% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $314K +$183K +140% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $260K +$91.7K +54.4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $52.9K -$152K -74.2% Dec 31, 2022 10-K 2025-03-27
Q3 2022 $92K -$149K -61.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $131K -$146K -52.7% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $168K Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $205K Dec 31, 2021 10-K 2024-03-18
Q3 2021 $241K Sep 30, 2021 10-Q 2021-11-01
Q2 2021 $277K Jun 30, 2021 10-Q 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.